Access the full text.
Sign up today, get DeepDyve free for 14 days.
F. Bortolotti, Laura Ukovich, V. Razban, V. Martinelli, G. Ruozi, Barbara Pelos, F. Dore, M. Giacca, S. Zacchigna (2015)
In Vivo Therapeutic Potential of Mesenchymal Stromal Cells Depends on the Source and the Isolation ProcedureStem Cell Reports, 4
V. Vaněček, K. Klíma, A. Kohout, R. Foltán, O. Jiroušek, J. Šedý, J. Štulík, E. Sykova, P. Jendelová (2013)
The combination of mesenchymal stem cells and a bone scaffold in the treatment of vertebral body defectsEuropean Spine Journal, 22
Katrin Frölich, A. Scherzed, R. Mlynski, A. Technau, R. Hagen, N. Kleinsasser, A. Radeloff (2010)
Multipotent Stromal Cells for Autologous Cell Therapy Approaches in the Guinea Pig ModelORL, 73
K. Kashiwa, N. Kotobuki, M. Tadokoro, K. Matsumura, S. Hyon, S. Yoshiya, H. Ohgushi (2010)
Effects of epigallocatechin gallate on osteogenic capability of human mesenchymal stem cells after suspension in phosphate-buffered saline.Tissue engineering. Part A, 16 1
J. Wysocki (2005)
Topographical anatomy of the guinea pig temporal boneHearing Research, 199
Y. Kim, Seung Park, Beomyong Shin, Jangho Kim, S. Kim, O. Choo, Xiang Yin, B. Min, Y. Choung (2017)
Osteogenesis for postoperative temporal bone defects using human ear adipose-derived stromal cells and tissue engineering: An animal model study.Journal of biomedical materials research. Part A, 105 12
T. Squillaro, G. Peluso, U. Galderisi (2016)
Clinical Trials with Mesenchymal Stem Cells: An UpdateCell Transplantation, 25
I. Murray, C. West, W. Hardy, A. James, T. Park, Alan Nguyen, T. Tawonsawatruk, L. Lazzari, C. Soo, B. Péault (2014)
Natural history of mesenchymal stem cells, from vessel walls to culture vesselsCellular and Molecular Life Sciences, 71
Jeongmin Seong, Byung-Chul Kim, Jae-Hong Park, I. Kwon, A. Mantalaris, Y. Hwang (2010)
Stem cells in bone tissue engineeringBiomedical Materials, 5
Hailang Luo, Yong-jie Zhang, Ziqiang Zhang, Yan Jin (2012)
The protection of MSCs from apoptosis in nerve regeneration by TGFβ1 through reducing inflammation and promoting VEGF-dependent angiogenesis.Biomaterials, 33 17
R. Boomsma, D. Geenen (2012)
Mesenchymal Stem Cells Secrete Multiple Cytokines That Promote Angiogenesis and Have Contrasting Effects on Chemotaxis and ApoptosisPLoS ONE, 7
J. Kaplan, M. Youd, T. Lodie (2011)
Immunomodulatory activity of mesenchymal stem cells.Current stem cell research & therapy, 6 4
B. Leatherman, J. Dornhoffer (2002)
Bioactive Glass Ceramic Particles as an Alternative for Mastoid Obliteration: Results in an Animal ModelOtology & Neurotology, 23
H. Lee, H. Lim, Minhyuk Cho, Suk-Min Yang, Keehyun Park, H. Park, Y. Choung (2013)
Clinical Significance of β-Tricalcium Phosphate and Polyphosphate for Mastoid Cavity Obliteration during Middle Ear Surgery: Human and Animal StudyClinical and Experimental Otorhinolaryngology, 6
V. Vallone, M. Romaniuk, Hosoon Choi, V. Labovsky, J. Otaegui, N. Chasseing (2013)
Mesenchymal stem cells and their use in therapy: what has been achieved?Differentiation; research in biological diversity, 85 1-2
L. Školoudík, V. Chrobok, D. Kalfeřt, Z. Kočí, E. Sykova, Tetyana Chumak, J. Popelář, J. Syka, J. Laco, J. Dědková, G. Dayanithi, S. Filip (2016)
Human Multipotent Mesenchymal Stromal Cells in the Treatment of Postoperative Temporal Bone Defect: An Animal ModelCell Transplantation, 25
A Harris, B. Mettias, T. Lesser (2016)
Pooled analysis of the evidence for open cavity, combined approach and reconstruction of the mastoid cavity in primary cholesteatoma surgeryThe Journal of Laryngology & Otology, 130
F. Amiri, A. Jahanian-Najafabadi, Mehryar Roudkenar (2014)
In vitro augmentation of mesenchymal stem cells viability in stressful microenvironmentsCell Stress and Chaperones, 20
C. Jang, Y. Cho, C. Choi, Y. Jang, Won‐Kyo Jung, Hyeongjin Lee, Geun Kim (2014)
Effect of umbilical cord serum coated 3D PCL/alginate scaffold for mastoid obliteration.International journal of pediatric otorhinolaryngology, 78 7
S. Méndez-Ferrer, T. Michurina, F. Ferraro, Amin Mazloom, B. MacArthur, S. Lira, D. Scadden, Avi Ma’ayan, G. Enikolopov, P. Frenette (2010)
Mesenchymal and haematopoietic stem cells form a unique bone marrow nicheNature, 466
L. Školoudík, V. Chrobok, D. Kalfeřt, Z. Kočí, S. Filip (2014)
Multipotent mesenchymal stromal cells in otorhinolaryngology.Medical hypotheses, 82 6
Hideaki Suzuki, S. Ikezaki, K. Imazato, H. Koizumi, T. Ohbuchi, N. Hohchi, K. Hashida (2014)
Partial Mastoid Obliteration Combined With Soft-wall Reconstruction for Middle Ear CholesteatomaAnnals of Otology, Rhinology & Laryngology, 123
M. Madrigal, Kosagisharaf Rao, N. Riordan (2014)
A review of therapeutic effects of mesenchymal stem cell secretions and induction of secretory modification by different culture methodsJournal of Translational Medicine, 12
Z. Gamie, R. Macfarlane, A. Tomkinson, Alexandros Moniakis, G. Tran, Yehya Gamie, A. Mantalaris, E. Tsiridis (2014)
Skeletal tissue engineering using mesenchymal or embryonic stem cells: clinical and experimental dataExpert Opinion on Biological Therapy, 14
S. Pacini, I. Petrini (2014)
Are MSCs angiogenic cells? New insights on human nestin-positive bone marrow-derived multipotent cellsFrontiers in Cell and Developmental Biology, 2
V. Franco-Vidal, G. Daculsi, M. d’Arc, O. Sterkers, M. Smail, A. Robier, P. Bordure, P. Clarós, A. Paiva, V. Darrouzet, Emmanuelle Anthoine, J. Bébéar (2014)
Tolerance and osteointegration of TricOsTM/MBCP® in association with fibrin sealant in mastoid obliteration after canal wall-down technique for cholesteatomaActa Oto-Laryngologica, 134
L. Tuček, Z. Kočí, K. Karova, H. Doležalová, J. Suchánek (2017)
The Osteogenic Potential of Human Nondifferentiated and Pre-differentiated Mesenchymal Stem Cells Combined with an Osteoconductive Scaffold - Early Stage Healing.Acta medica, 60 1
M. Dominici, K. Blanc, Ingo Mueller, I. Slaper-Cortenbach, F. Marini, D. Krause, R. Deans, A. Keating, D. Prockop, E. Horwitz (2006)
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.Cytotherapy, 8 4
Jagwant Singh, J. Onimowo, W. Khan (2014)
Bone marrow derived stem cells in trauma and orthopaedics: a review of the current trend.Current stem cell research & therapy, 10 1
Karolina Turnovcova, K. Růžičková, V. Vaněček, E. Sykova, P. Jendelová (2009)
Properties and growth of human bone marrow mesenchymal stromal cells cultivated in different media.Cytotherapy, 11 7
C. Seebach, D. Henrich, K. Wilhelm, J. Barker, I. Marzi (2012)
Endothelial Progenitor Cells Improve Directly and Indirectly Early Vascularization of Mesenchymal Stem Cell-Driven Bone Regeneration in a Critical Bone Defect in RatsCell Transplantation, 21
B. Murray, D. Wilson (2004)
A study of metabolites as intermediate effectors in angiogenesisAngiogenesis, 4
F Amiri, A Jahanian-Najafabadi, MH Roudkenar (2015)
In vitro augmentation of mesenchymal stem cells viability in stressful microenvironments: In vitro augmentation of mesenchymal stem cells viabilityCell Sterss and Chaperones, 20
Han Peng, Leiguo Ming, R. Yang, Yang Liu, Yuan-yuan Liang, Yu Zhao, Yan Jin, Z. Deng (2013)
The use of laryngeal mucosa mesenchymal stem cells for the repair the vocal fold injury.Biomaterials, 34 36
Temporal bone reconstruction is a persisting problem following middle ear cholesteatoma surgery. Seeking to advance the clinical transfer of stem cell therapy we attempted the reconstruction of temporal bone using a composite bioartificial graft based on a hydroxyapatite bone scaffold combined with human bone marrow-derived mesenchymal stromal cells (hBM-MSCs). The aim of this study was to evaluate the effect of the combined biomaterial on the healing of postoperative temporal bone defects and the preservation of physiological hearing functions in a guinea pig model. The treatment’s effect could be observed at 1 and 2 months after implantation of the biomaterial, as opposed to the control group. The clinical evaluation of our results included animal survival, clinical signs of an inflammatory response, and exploration of the tympanic bulla. Osteogenesis, angiogenesis, and inflammation were evaluated by histopathological analyses, whereas hBM-MSCs survival was evaluated by immunofluorescence assays. Hearing capacity was evaluated by objective audiometric methods, i.e. auditory brainstem responses and otoacoustic emission. Our study shows that hBM-MSCs, in combination with hydroxyapatite scaffolds, improves the repair of bone defects providing a safe and effective alternative in their treatment following middle ear surgery due to cholesteatoma.
Stem Cell Reviews and Reports – Springer Journals
Published: Jun 3, 2018
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.